tiprankstipranks
Advertisement
Advertisement

TEVA Stock Latest News

With $1 Billion Share Sale, Apotex Health Is Canada’s Biggest IPO in Years
Market NewsWith $1 Billion Share Sale, Apotex Health Is Canada’s Biggest IPO in Years
3d ago
IPO
TEVA
Teva Shareholders Back Board, Executive Pay and Auditor
PremiumCompany Announcements
Teva Shareholders Back Board, Executive Pay and Auditor
6d ago
8K
TEVA
Teva commits to Veeva Vault CRM
PremiumThe Fly
Teva commits to Veeva Vault CRM
8d ago
TEVA
VEEV
Teva announces EMA acceptance of MAA for olanzapine long-acting injectable
PremiumThe Fly
Teva announces EMA acceptance of MAA for olanzapine long-acting injectable
14d ago
TEVA
Einhorn’s DME takes stakes in StubHub, Paramount, buys more Peloton
PremiumThe Fly
Einhorn’s DME takes stakes in StubHub, Paramount, buys more Peloton
17d ago
KD
BHF
Teva put volume heavy and directionally bearish
PremiumThe FlyTeva put volume heavy and directionally bearish
20d ago
TEVA
Teva, Upstart, Bloom, Corning, Seagate Insider Shock
Premium
Weekend Updates
Teva, Upstart, Bloom, Corning, Seagate Insider Shock
26d ago
BE
GLW
Teva price target raised to $40 from $38 at Barclays
Premium
The Fly
Teva price target raised to $40 from $38 at Barclays
28d ago
TEVA
Teva Earnings Call Highlights Innovative-Driven Margin Upswing
PremiumCompany Announcements
Teva Earnings Call Highlights Innovative-Driven Margin Upswing
29d ago
TEVA
Teva price target raised to $50 from $45 at Goldman Sachs
PremiumThe Fly
Teva price target raised to $50 from $45 at Goldman Sachs
1M ago
TEVA
Teva price target raised to $40 from $35 at JPMorgan
PremiumThe Fly
Teva price target raised to $40 from $35 at JPMorgan
1M ago
TEVA
Teva price target raised to $42 from $41 at Piper Sandler
PremiumThe Fly
Teva price target raised to $42 from $41 at Piper Sandler
1M ago
TEVA
Teva price target raised to $42 from $36 at UBS
PremiumThe FlyTeva price target raised to $42 from $36 at UBS
1M ago
TEVA
Teva Upgraded to $45 Price Target on Strong Execution, Emalex Acquisition, and Growing Neurology Pipeline Upside
Premium
Ratings
Teva Upgraded to $45 Price Target on Strong Execution, Emalex Acquisition, and Growing Neurology Pipeline Upside
1M ago
TEVA
Teva price target raised to $45 from $42 at Truist
Premium
The Fly
Teva price target raised to $45 from $42 at Truist
1M ago
TEVA
Unusually active option classes on open April 29th
PremiumThe Fly
Unusually active option classes on open April 29th
1M ago
CVS
Teva says making ‘great progress’ on Pivot to Growth strategy
PremiumThe Fly
Teva says making ‘great progress’ on Pivot to Growth strategy
1M ago
TEVA
Teva says ‘on track’ to achieve 2027 financial targets
PremiumThe Fly
Teva says ‘on track’ to achieve 2027 financial targets
1M ago
TEVA
Teva says has greater than $10B of innovative pipeline potential
PremiumThe Fly
Teva says has greater than $10B of innovative pipeline potential
1M ago
TEVA
Teva seeing ‘significant progress’ with transformation programs
PremiumThe FlyTeva seeing ‘significant progress’ with transformation programs
1M ago
TEVA
Teva expects revenue to ‘gradually increase’ over course of year
Premium
The Fly
Teva expects revenue to ‘gradually increase’ over course of year
1M ago
TEVA
Morning Movers: NXP Semi, Bloom Energy charged up after results
Premium
The Fly
Morning Movers: NXP Semi, Bloom Energy charged up after results
1M ago
BE
GD

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >